←Back to Portfolio
Biotech & VaccinesDirect Investment (SME)Europe
StablePharma
StablePharma is pioneering fridge-free vaccine stabilisation technology that has the potential to transform global health outcomes. Their platform enables vaccines to be stored and transported without cold-chain infrastructure, dramatically expanding access in developing markets.
Investment Thesis
Cold-chain logistics remain one of the biggest barriers to vaccine distribution in the developing world. StablePharma's technology addresses a fundamental infrastructure gap, with implications far beyond any single disease or geography.
Key Highlights
◆
Proprietary vaccine stabilisation platform
◆
Eliminates cold-chain dependency
◆
Significant global health impact potential